Crossmark Global Holdings, Inc. Cardiovascular Systems Inc Transaction History

Crossmark Global Holdings, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 14, 2021	SELL	$34.3 - $44.09 $281,260 - $361,538	-8,200 Closed	0 $0
Q3 2020 Oct 08, 2020	BUY	$27.86 - $39.35 $3,621 - $5,115	130 Added 1.61%	8,200 $323,000
Q2 2020 Aug 14, 2020	BUY	$30.3 - $42.55 $909 - $1,276	30 Added 0.37%	8,070 $255,000
Q1 2020 Apr 28, 2020	SELL	$30.0 - $54.18 $3,000 - $5,418	-100 Reduced 1.23%	8,040 $283,000
Q4 2019 Feb 06, 2020	SELL	$42.29 - $52.2 $106,147 - $131,022	-2,510 Reduced 23.57%	8,140 $396,000
Q3 2019 Oct 09, 2019	SELL	$42.06 - $51.64 $4,206 - $5,164	-100 Reduced 0.93%	10,650 $506,000
Q2 2019 Jul 09, 2019	SELL	$33.93 - $43.66 $16,965 - $21,830	-500 Reduced 4.44%	10,750 $461,000
Q1 2019 May 02, 2019	BUY	$26.74 - $41.32 $300,825 - $464,850	11,250 New	11,250 $435,000

35.5K

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.